BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29329996)

  • 1. To prep or not to prep - that is the question: A randomized trial on the use of antiflatulent medication as part of bowel preparation for patients having image guided external beam radiation therapy to the prostate.
    McGuffin M; Devji N; Kehoe L; Carty A; Russell S; Di Prospero L; DeAngelis C; Kiss A; Vesprini D; Loblaw A; D'Alimonte L
    Pract Radiat Oncol; 2018; 8(2):116-122. PubMed ID: 29329996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer.
    Hosni A; Rosewall T; Craig T; Kong V; Bayley A; Berlin A; Bristow R; Catton C; Warde P; Chung P
    Radiat Oncol; 2017 Mar; 12(1):50. PubMed ID: 28279179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: Toxicity, biochemical, and patient-reported health-related quality-of-life outcomes.
    Berlin A; Cho E; Kong V; Howell KJ; Lao B; Craig T; Bayley A; Chung P; Gospodarowicz M; Warde P; Catton C; Bristow RG; Ménard C
    Pract Radiat Oncol; 2015; 5(5):e473-e482. PubMed ID: 25899220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer.
    Li M; Li GF; Hou XY; Gao H; Xu YG; Zhao T
    Chin Med J (Engl); 2016 Jun; 129(12):1447-54. PubMed ID: 27270540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does rectum and bladder dose vary during the course of image-guided radiotherapy in the postprostatectomy setting?
    Akin M; Öksüz DC; Iktueren B; Ambarcioglu P; Karacam S; Koca S; Dincbas FÖ
    Tumori; 2014; 100(5):529-35. PubMed ID: 25343548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion.
    Nichol AM; Warde PR; Lockwood GA; Kirilova AK; Bayley A; Bristow R; Crook J; Gospodarowicz M; McLean M; Milosevic M; Rosewall T; Jaffray DA; Catton CN
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1072-8. PubMed ID: 19783378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.
    de Crevoisier R; Bayar MA; Pommier P; Muracciole X; Pêne F; Dudouet P; Latorzeff I; Beckendorf V; Bachaud JM; Laplanche A; Supiot S; Chauvet B; Nguyen TD; Bossi A; Créhange G; Lagrange JL
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1420-1429. PubMed ID: 30071296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: treating to doses beyond 78 Gy.
    Eade TN; Guo L; Forde E; Vaux K; Vass J; Hunt P; Kneebone A
    BJU Int; 2012 Jun; 109(11):1655-60. PubMed ID: 22035373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence.
    Park SS; Yan D; McGrath S; Dilworth JT; Liang J; Ye H; Krauss DJ; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):947-52. PubMed ID: 22208964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter- and intrafraction uncertainty in prostate bed image-guided radiotherapy.
    Huang K; Palma DA; Scott D; McGregor D; Gaede S; Yartsev S; Bauman G; Louie AV; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):402-7. PubMed ID: 22381905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.
    Barkati M; Simard D; Taussky D; Delouya G
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):255-9. PubMed ID: 26568515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial on the effect of simethicone bowel preparation on rectal variability during image-guided radiation therapy for prostate cancer (SPoRT study).
    Ward J; Gill S; Armstrong K; Fogarty T; Tan D; Scott A; Yahya A; Dhaliwal SS; Jacques A; Tang C
    J Med Imaging Radiat Oncol; 2022 Sep; 66(6):866-873. PubMed ID: 35322563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience.
    Hamstra DA; Conlon AS; Daignault S; Dunn RL; Sandler HM; Hembroff AL; Zietman AL; Kaplan I; Ciezki J; Kuban DA; Wei JT; Sanda MG; Michalski JM;
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):546-53. PubMed ID: 23561651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.
    Nakamura K; Mizowaki T; Inokuchi H; Ikeda I; Inoue T; Kamba T; Ogawa O; Hiraoka M
    Int J Clin Oncol; 2018 Feb; 23(1):158-164. PubMed ID: 28756594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study.
    Ohashi T; Yorozu A; Saito S; Tanaka N; Katayama N; Kojima S; Maruo S; Kikuchi T; Dokiya T; Fukushima M; Yamanaka H
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):141-9. PubMed ID: 26279031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.